Preliminary evidence from this study indicates that ccfDNA levels are closely linked to immune dysfunction and may have potential as a complementary biomarker for monitoring immune status in HIV-1-infected patients.
Cheng et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: